ID

35973

Descrizione

Study of ARC-520 in Patients With Chronic Hepatitis B Virus; ODM derived from: https://clinicaltrials.gov/show/NCT02065336

collegamento

https://clinicaltrials.gov/show/NCT02065336

Keywords

versioni (1)
  1. 08/04/19 08/04/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

8 aprile 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis B, Chronic NCT02065336

Inglese

Eligibility Hepatitis B, Chronic NCT02065336

1 moduli  
Criteria
Descrizione

Criteria

have a diagnosis of hbeag negative, immune active, chronic hbv infection and all of the following:
Descrizione

Chronic Hepatitis B HBeAg Negative | Chronic Hepatitis B Active Immune Response

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0524909
UMLS CUI [1,2]
C0019167
UMLS CUI [1,3]
C1513916
UMLS CUI [2,1]
C0524909
UMLS CUI [2,2]
C2936721
1. history of being hbsag positive at 2 time points > 6 months apart
Descrizione

Hepatitis B surface antigen positive Timepoint Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0149709
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C1265611
2. hbsag titer > 1,000 iu/ml determined at screening
Descrizione

Hepatitis B Surface Antigens Titer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C0475208
3. hbeag negative at screening
Descrizione

Hepatitis B e Antigens Negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019167
UMLS CUI [1,2]
C1513916
4. hbv dna < 200 iu/ml at screening
Descrizione

Hepatitis B DNA Measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3641250
patients with > 6 months of continuous, 0.5 mg/day oral entecavir, and a willingness to continue taking entecavir throughout the study.
Descrizione

Entecavir Oral Product U/day | entecavir

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3216232
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C0971023
key exclusion criteria:
Descrizione

Exclusion Criteria Main

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
female patients that have a positive pregnancy test or are lactating.
Descrizione

Pregnancy test positive | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0240802
UMLS CUI [2]
C0006147
acute signs of hepatitis/other infection (eg, moderate fever, jaundice, nausea, vomiting, and abdominal pain) evident within 4 weeks of screening and/or at the screening examination.
Descrizione

Signs Hepatitis | Signs Communicable Disease | Fever Moderate | Jaundice | Nausea | Vomiting | Abdominal Pain

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0311392
UMLS CUI [1,2]
C0019158
UMLS CUI [2,1]
C0311392
UMLS CUI [2,2]
C0009450
UMLS CUI [3,1]
C0015967
UMLS CUI [3,2]
C0205081
UMLS CUI [4]
C2010848
UMLS CUI [5]
C0027497
UMLS CUI [6]
C0042963
UMLS CUI [7]
C0000737
hepatic transaminases (alt or ast) > 100 iu/ml at screening.
Descrizione

Transaminase Assay Hepatic | Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0919834
UMLS CUI [1,2]
C0205054
UMLS CUI [2]
C0201836
UMLS CUI [3]
C0201899
patients with antiviral therapy other than entecavir within 3 months of screening or prior treatment with interferon or a toll receptor agonist in the last 5 years.
Descrizione

Antiviral Therapy | Exception Entecavir | Prior interferon therapy | Toll-Like Receptor Agonist Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0280274
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0971023
UMLS CUI [3]
C0278953
UMLS CUI [4]
C1883683
use within the last 6 months or an anticipated requirement for anticoagulants, corticosteroids, immunomodulators, or immunosuppressants.
Descrizione

Anticoagulants | Adrenal Cortex Hormones | Immunomodulators | Immunosuppressive Agents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003280
UMLS CUI [2]
C0001617
UMLS CUI [3]
C1527392
UMLS CUI [4]
C0021081
has any history of autoimmune disease especially autoimmune hepatitis.
Descrizione

Autoimmune Disease | Hepatitis, Autoimmune

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0241910
has human immunodeficiency virus (hiv) infection, as shown by the presence of anti-hiv antibody (sero-positive).
Descrizione

HIV Infection | Seropositive HIV antibody

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2,1]
C0521143
UMLS CUI [2,2]
C0019683
is sero-positive for hcv, and/or a history of delta virus hepatitis.
Descrizione

Seropositive Hepatitis C virus | Hepatitis Delta Virus

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0521143
UMLS CUI [1,2]
C0220847
UMLS CUI [2]
C0011220
has a history of allergy to bee venom or history of hypersensitivity reaction requiring an emergency visit to a physician or hospital and/or requirement for treatment with steroids and/or epinephrine.
Descrizione

Allergy to bee venom | Allergic Reaction Requirement Emergency visit | Allergic Reaction Requirement Emergency department patient visit | Allergic Reaction Requirement Steroids | Allergic Reaction Requirement Epinephrine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1828283
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0553618
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0586082
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C1514873
UMLS CUI [4,3]
C0038317
UMLS CUI [5,1]
C1527304
UMLS CUI [5,2]
C1514873
UMLS CUI [5,3]
C0014563
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis B, Chronic NCT02065336

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Chronic Hepatitis B HBeAg Negative | Chronic Hepatitis B Active Immune Response
Item
have a diagnosis of hbeag negative, immune active, chronic hbv infection and all of the following:
boolean
C0524909 (UMLS CUI [1,1])
C0019167 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
C0524909 (UMLS CUI [2,1])
C2936721 (UMLS CUI [2,2])
Hepatitis B surface antigen positive Timepoint Quantity
Item
1. history of being hbsag positive at 2 time points > 6 months apart
boolean
C0149709 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Hepatitis B Surface Antigens Titer
Item
2. hbsag titer > 1,000 iu/ml determined at screening
boolean
C0019168 (UMLS CUI [1,1])
C0475208 (UMLS CUI [1,2])
Hepatitis B e Antigens Negative
Item
3. hbeag negative at screening
boolean
C0019167 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
Hepatitis B DNA Measurement
Item
4. hbv dna < 200 iu/ml at screening
boolean
C3641250 (UMLS CUI [1])
Entecavir Oral Product U/day | entecavir
Item
patients with > 6 months of continuous, 0.5 mg/day oral entecavir, and a willingness to continue taking entecavir throughout the study.
boolean
C3216232 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0971023 (UMLS CUI [2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Pregnancy test positive | Breast Feeding
Item
female patients that have a positive pregnancy test or are lactating.
boolean
C0240802 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Signs Hepatitis | Signs Communicable Disease | Fever Moderate | Jaundice | Nausea | Vomiting | Abdominal Pain
Item
acute signs of hepatitis/other infection (eg, moderate fever, jaundice, nausea, vomiting, and abdominal pain) evident within 4 weeks of screening and/or at the screening examination.
boolean
C0311392 (UMLS CUI [1,1])
C0019158 (UMLS CUI [1,2])
C0311392 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
C0015967 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C2010848 (UMLS CUI [4])
C0027497 (UMLS CUI [5])
C0042963 (UMLS CUI [6])
C0000737 (UMLS CUI [7])
Transaminase Assay Hepatic | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
hepatic transaminases (alt or ast) > 100 iu/ml at screening.
boolean
C0919834 (UMLS CUI [1,1])
C0205054 (UMLS CUI [1,2])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Antiviral Therapy | Exception Entecavir | Prior interferon therapy | Toll-Like Receptor Agonist Therapy
Item
patients with antiviral therapy other than entecavir within 3 months of screening or prior treatment with interferon or a toll receptor agonist in the last 5 years.
boolean
C0280274 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0971023 (UMLS CUI [2,2])
C0278953 (UMLS CUI [3])
C1883683 (UMLS CUI [4])
Anticoagulants | Adrenal Cortex Hormones | Immunomodulators | Immunosuppressive Agents
Item
use within the last 6 months or an anticipated requirement for anticoagulants, corticosteroids, immunomodulators, or immunosuppressants.
boolean
C0003280 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
C1527392 (UMLS CUI [3])
C0021081 (UMLS CUI [4])
Autoimmune Disease | Hepatitis, Autoimmune
Item
has any history of autoimmune disease especially autoimmune hepatitis.
boolean
C0004364 (UMLS CUI [1])
C0241910 (UMLS CUI [2])
HIV Infection | Seropositive HIV antibody
Item
has human immunodeficiency virus (hiv) infection, as shown by the presence of anti-hiv antibody (sero-positive).
boolean
C0019693 (UMLS CUI [1])
C0521143 (UMLS CUI [2,1])
C0019683 (UMLS CUI [2,2])
Seropositive Hepatitis C virus | Hepatitis Delta Virus
Item
is sero-positive for hcv, and/or a history of delta virus hepatitis.
boolean
C0521143 (UMLS CUI [1,1])
C0220847 (UMLS CUI [1,2])
C0011220 (UMLS CUI [2])
Allergy to bee venom | Allergic Reaction Requirement Emergency visit | Allergic Reaction Requirement Emergency department patient visit | Allergic Reaction Requirement Steroids | Allergic Reaction Requirement Epinephrine
Item
has a history of allergy to bee venom or history of hypersensitivity reaction requiring an emergency visit to a physician or hospital and/or requirement for treatment with steroids and/or epinephrine.
boolean
C1828283 (UMLS CUI [1])
C1527304 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0553618 (UMLS CUI [2,3])
C1527304 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0586082 (UMLS CUI [3,3])
C1527304 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0038317 (UMLS CUI [4,3])
C1527304 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C0014563 (UMLS CUI [5,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial